| Stage | IRM | % of rev | EXR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.0B | 100.00% | $890M | 100.00% | IRM ×2.28 |
| Gross profit | $1.1B | 52.76% | $651M | 73.16% | EXR +20.4pp |
| Operating income | $374M | 18.41% | $392M | 44.04% | EXR +25.6pp |
| Pre-tax income | $121M | 5.96% | $268M | 30.16% | EXR +24.2pp |
| Net income | $106M | 5.23% | $259M | 29.16% | EXR +23.9pp |
| Stage | IRM | EXR | Gap · A − B |
|---|---|---|---|
| Revenue | $2.0B100.00% | $890M100.00% | IRM ×2.28 |
| Gross profit | 52.76%$1.1B | 73.16%$651M | EXR +20.4pp |
| Operating income | 18.41%$374M | 44.04%$392M | EXR +25.6pp |
| Pre-tax income | 5.96%$121M | 30.16%$268M | EXR +24.2pp |
| Net income |
| 5.23%$106M |
| 29.16%$259M |
| EXR +23.9pp |